Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00715923 · ClinicalTrials.gov registry record · NA

Modified Consent Form Utility

A NA study, sponsored by University of California, Davis.

Terminated
Registry status
NA
Development phase
30
Enrollment target

NCT00715923: Clinical Trial NA study, sponsored by University of California, Davis.

NCT00715923 is a NA study that was terminated before completion, run by University of California, Davis. The registered enrollment target is 30 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00715923, a NA study, was terminated before completion, sponsored by University of California, Davis.

TERMINATED
Registry status
NA
Development phase
30 participants
Enrollment target

Study Summary

Subjects enrolling into a nutrition study of the effects of tea on fat absorption will be randomized to receive either a standard informed consent document or a modified document that is shorter and more easily understood than the standard document. The hypothesis is that using a shorter form that is more easily understood and more visually simple will lead to greater subject satisfaction in the consent process and will not compromise subject comprehension of key study aspects. Consent for study inclusion has been waived by the IRB because informing subjects of the nature and process of the study would likely affect the findings, and both the standard and modified consent forms were approved for use in the nutrition study.

Interventions

  • OTHER Modified consent form
  • OTHER Standard consent form

Trial Details

FieldValue
Enrollment Target 30 participants
Start Date 2007-11
Est. Completion 2008-12
Phase NA
University of California, Davis

657 total trials

Why NCT00715923 stopped before completion

NCT00715923 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 30 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).

The record links to 0 conditions, and to 2 interventions - of which Modified consent form is the first listed.

NCT00715923 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT00715923 about?

NCT00715923 is a clinical study titled "Modified Consent Form Utility". Subjects enrolling into a nutrition study of the effects of tea on fat absorption will be randomized to receive either a standard informed consent document or a modified document that is shorter and more easily understood than the standard document. The hypothesis is that using a shorter form that i...

What is the current status of trial NCT00715923?

This trial is currently terminated. It is a NA study. The enrollment target is 30 participants. The study started on 2007-11. Estimated completion is 2008-12.

What interventions are being tested in trial NCT00715923?

The interventions under investigation include: Modified consent form (OTHER), Standard consent form (OTHER).

Who is sponsoring clinical trial NCT00715923?

This trial is sponsored by University of California, Davis, which has 657 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT00715923's enrollment target sits among peer trials

30 1593rd of 2000 higher than 299 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00977977 · 30 participants · Phase 2

    Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy

  • NCT01459107 · 30 participants · Phase 2

    Human Upper Extremity Allotransplantation

  • NCT01666080 · 30 participants · NA

    Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)

  • NCT01720836 · 30 participants · Phase 1

    Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00715923, the US trial registry maintained by the National Library of Medicine. NCT00715923 (small enrollment · none site footprint · terminated) retrieved and formatted by PlainTrial, see methodology.